Oddball product names are one of the occupational hazards of biotech writing. Drugs in particular can be hard to spell, and often hard to pronounce. While I can practically type telaprevir, telaprevir, telaprevir in my sleep at this point, I can almost feel the reader reaction when that scientific name flows from my keyboard.
ZZZ….
Alas, there’s no Steve Jobs-style marketing whiz in this business, handing down tablets from the heavens, and bestowing upon them a magical name like “iPad.” But lately, the business of giving brand names to prescription drugs seems to have gone from boring to weird.
To read the full, original article click on this link: Why Are Drugs Getting Such Weird Brand Names? | Xconomy
Author: Luke Timmerman
